[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100608095":3},{"organization":4,"armGroups":7,"interventions":7,"overallOfficials":7,"centralContacts":8,"locations":17,"responsibleParty":33,"collaborators":7,"id":37,"slug":38,"hasResults":39,"nctId":40,"briefTitle":41,"officialTitle":42,"acronym":43,"eligibilityCriteria":44,"healthyVolunteers":39,"sex":45,"minAge":7,"maxAge":7,"enrollmentInfo":46,"targetDuration":7,"studyType":49,"phases":7,"briefSummary":50,"conditions":51,"keywords":7,"overallStatus":20,"whyStopped":7,"lastUpdateSubmitDate":53,"lastUpdatePostDateStruct":54,"startDateStruct":57,"completionDateStruct":59,"leadSponsor":61,"locationsCount":62},{"fullName":5,"class":6},"Al-Azhar University","OTHER",null,[9,14],{"name":10,"role":11,"phone":12,"phoneExt":7,"email":13},"Wajdi Hamid Eisay, MD","CONTACT","00218911103885","wajdyessa91@gmail.com",{"name":15,"role":11,"phone":16,"phoneExt":7,"email":7},"Hussein Mohammed Hussein, Professor","00201005196285",[18],{"facility":19,"status":20,"city":21,"state":7,"zip":7,"country":22,"countryCode":23,"cosmosGeoPoint":24,"geoPoint":29,"contacts":30},"Al-Azhar University Hospitals","RECRUITING","Cairo","Egypt","EG",{"type":25,"coordinates":26},"Point",[27,28],31.24967,30.06263,{"lat":28,"lon":27},[31],{"name":10,"role":11,"phone":32,"phoneExt":7,"email":13},"00201097429385",{"type":34,"investigatorFullName":35,"investigatorTitle":36,"investigatorAffiliation":5,"oldNameTitle":7,"oldOrganization":7},"PRINCIPAL_INVESTIGATOR","Wajdi Hamid Miftah Eisay","resident","100608095","evaluation-for-therapeutic-plasma-exchange-for-immune-mediated-neurological-disease-100608095",false,"NCT07197099","Evaluation for Therapeutic Plasma Exchange for Immune Mediated Neurological Disease","Evaluation of Therapeutic Plasma Exchange for Immune-Mediated Neurological Diseases in a Sample of Egyptian Patients: An Experience at Al-Azhar University Hospitals","TPE","Inclusion Criteria:\n\n* 1\\. All neurological patients irrespective of age who will undergo TPE. 2.All new and relapse cases that meet the ASFA guidelines and where TPE is the first and\u002For second line of therapy\n\nExclusion Criteria:\n\n* 1\\. Individuals with contraindications to therapeutic plasma exchange, such as hemodynamic unstable, hypocalcaemia, allergy to fresh frozen plasma or albumin.\n\n  2.Patients who will undergo fewer than five cycles of TPE and not complete the procedure.\n\n  3.Patients with non-neurological disorders.","ALL",{"count":47,"type":48},60,"ESTIMATED","OBSERVATIONAL","The goal of this observational study is to Evaluation of Therapeutic Plasma Exchange for Immune-Mediated Neurological Diseases in a Sample of Egyptian Patients: An Experience at Al-Azhar University Hospitals, including evaluating clinical response rates and functional improvement.",[52],"Neurological Autoimmune Diseases","2025-11-15",{"date":55,"type":56},"2025-11-18","ACTUAL",{"date":58,"type":56},"2025-01-01",{"date":60,"type":48},"2025-12-31",{"name":5,"class":6},1]